As these are dynamic metrics associated with weight gain during pregnancy, their measurement in the second or third trimester would enhance our understanding of the link between NAFLD, Hb concentration, and GDM. This evidence concerns the gene GSTM1 and metabolic dysfunction-associated steatotic liver disease.